SLN•benzinga•
Silence Therapeutics Q1 EPS $(0.20) Down From $(0.05) YoY, Sales $142.00K Down From $15.73M YoY
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga